Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Opko Health Inc (NASDAQ: OPK) was $1.30 for the day, down -2.26% from the previous closing price of $1.33. In other words, the price has decreased by -$2.26 from its previous closing price. On the day, 1.74 million shares were traded.
Ratios:
Our analysis of OPK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.28.
On June 29, 2023, Barrington Research Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $2.
On December 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $3.H.C. Wainwright initiated its Buy rating on December 15, 2022, with a $3 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 10 ’25 when FROST PHILLIP MD ET AL bought 125,000 shares for $1.36 per share. The transaction valued at 169,712 led to the insider holds 214,001,448 shares of the business.
FROST PHILLIP MD ET AL bought 125,000 shares of OPK for $184,650 on Apr 08 ’25. The CEO & Chairman now owns 213,876,448 shares after completing the transaction at $1.48 per share. On Apr 01 ’25, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 100,000 shares for $1.65 each. As a result, the insider paid 164,850 and bolstered with 213,751,448 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.50 while its Price-to-Book (P/B) ratio in mrq is 0.67.
Stock Price History:
Over the past 52 weeks, OPK has reached a high of $2.04, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -13.43%, while the 200-Day Moving Average is calculated to be -15.81%.
Shares Statistics:
A total of 671.61M shares are outstanding, with a floating share count of 350.22M. Insiders hold about 55.84% of the company’s shares, while institutions hold 32.08% stake in the company.
Earnings Estimates
Currently, 1 analysts are dedicated to thoroughly evaluating and rating the performance of Opko Health Inc (OPK) in the stock market.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.37 and -$0.37 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is -$0.34, with 1.0 analysts recommending between -$0.34 and -$0.34.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $166.7M to a low estimate of $163.5M. As of the current estimate, Opko Health Inc’s year-ago sales were $182.2MFor the next quarter, 7 analysts are estimating revenue of $167.83M. There is a high estimate of $176.9M for the next quarter, whereas the lowest estimate is $147M.
A total of 7 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $680.7M, while the lowest revenue estimate was $616.35M, resulting in an average revenue estimate of $652.28M. In the same quarter a year ago, actual revenue was $713.1MBased on 7 analysts’ estimates, the company’s revenue will be $703.12M in the next fiscal year. The high estimate is $769.4M and the low estimate is $614M.
